Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy
- PMID: 20651586
- DOI: 10.1097/QAD.0b013e32833c93ce
Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy
Abstract
Background: Persistently reduced CD4(+) T-lymphocyte counts in the face of undetectable HIV viremia are seen in a sizable percentage of HIV-infected patients undergoing antiretroviral therapy (ART). We analyzed the immune correlates of this phenomenon.
Materials and methods: Sixty-seven HIV-infected patients with undetectable viremia (<50 copies/microl) after more than 7 years of ART were enrolled in the study and divided into two groups (CD4 cell counts >500 cells/microl or <500 cells/microl). Duration of HIV infection (>16 years) was comparable. Peripheral blood mononuclear cell were stimulated with gag+env or with cytomegalovirus peptides. Activated T cells (Ki67(+)), Treg lymphocytes (CD4(+)/CD25high/Foxp3+), divided into naive and activated cells based on PD1 expression, interleukin (IL)-10 and transforming growth factor (TGF)-beta production, annexin V, activation of caspases 8 and 9, Toll-like receptor (TLR)2 and TLR4 expression on immune cells, and plasma lipopolysaccharide (LPS) concentration were analyzed.
Results: CD4(+)/Ki67(+) T cells; plasma LPS; total, naive, and activated Treg; TLR2-expressing and TLR4-expressing Treg; IL-10 production; and early and late apoptotic CD4 T cells, were significantly increased in patients with undetectable viremia and CD4 cell counts less than 500 cells/microl after more than 7 years of ART. As previously shown, CD4 nadir were also lower in these individuals. Immune activation, LPS concentration, Treg, and degree of apoptosis were negatively correlated with CD4 cell counts.
Conclusion: Lack of CD4 recovery in individuals in whom ART suppresses HIV replication is associated with complex immune alterations. Immune activation, likely driven by altered gut permeability and resulting in augmented Treg activity could play a pivotal role in this process.
Similar articles
-
Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders.Blood. 2011 Sep 22;118(12):3263-72. doi: 10.1182/blood-2011-01-329060. Epub 2011 May 16. Blood. 2011. PMID: 21576701
-
Association of immune complexes and plasma viral load with CD4+ cell depletion, CD8+ DR+ and CD16+ cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4+ lymphocyte depletion.Immunol Lett. 2001 Mar 1;76(2):69-78. doi: 10.1016/s0165-2478(01)00181-x. Immunol Lett. 2001. PMID: 11274723
-
Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.HIV Med. 2015 Jan;16(1):48-56. doi: 10.1111/hiv.12171. Epub 2014 Jun 2. HIV Med. 2015. PMID: 24889179 Clinical Trial.
-
The role of cytokines in the pathogenesis and treatment of HIV infection.Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):207-14. doi: 10.1016/j.cytogfr.2012.05.007. Epub 2012 Jun 26. Cytokine Growth Factor Rev. 2012. PMID: 22738931 Free PMC article. Review.
-
HIV-Related Immune Activation and Inflammation: Current Understanding and Strategies.J Immunol Res. 2021 Sep 29;2021:7316456. doi: 10.1155/2021/7316456. eCollection 2021. J Immunol Res. 2021. PMID: 34631899 Free PMC article. Review.
Cited by
-
Improved induced innate immune response after cART initiation in people with HIV.Front Immunol. 2022 Aug 17;13:974767. doi: 10.3389/fimmu.2022.974767. eCollection 2022. Front Immunol. 2022. PMID: 36059528 Free PMC article.
-
Add-on Pyridostigmine Enhances CD4+ T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-of-Concept Study.Front Immunol. 2017 Oct 18;8:1301. doi: 10.3389/fimmu.2017.01301. eCollection 2017. Front Immunol. 2017. PMID: 29093707 Free PMC article.
-
Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection.Nutrients. 2011 Dec;3(12):1042-70. doi: 10.3390/nu3121042. Epub 2011 Dec 19. Nutrients. 2011. PMID: 22292110 Free PMC article.
-
Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature.BMC Infect Dis. 2018 Jan 5;18(1):8. doi: 10.1186/s12879-017-2942-3. BMC Infect Dis. 2018. PMID: 29304776 Free PMC article. Review.
-
Association between CD4+ T cell counts and gut microbiota and serum cytokines levels in HIV-infected immunological non-responders.BMC Infect Dis. 2021 Aug 3;21(1):742. doi: 10.1186/s12879-021-06491-z. BMC Infect Dis. 2021. PMID: 34344350 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials